Research Correspondence

DOI: 10.4244/EIJ-D-24-00911

Optical coherence tomography versus intravascular ultrasound- guided PCI in patients with and without acute coronary syndrome: a prespecified subanalysis of the OCTIVUS trial

Ju Hyeon Kim1,2, MD, PhD; Soon Jun Hong1, MD, PhD; Subin Lim1, MD, PhD; Jung-Joon Cha1, MD, PhD; Hyung Joon Joo1, MD, PhD; Jae Hyoung Park1, MD, PhD; Cheol Woong Yu1, MD, PhD; Do-Sun Lim1, MD, PhD; Do‐Yoon Kang2, MD, PhD; Jung‐Min Ahn2, MD, PhD; Duk‐Woo Park2, MD, PhD; Seung‐Jung Park2, MD, PhD

The latest European guidelines recommend intracoronary imaging (ICI) guidance by intravascular ultrasound (IVUS) or optical coherence tomography (OCT) for percutaneous coronary intervention (PCI) on anatomically complex lesions, particularly for left main stem, true bifurcations, and long lesions1. However, large-scale randomised studies comparing the efficacy between ICI-guided and angiography-guided PCI in patients with acute coronary syndrome (ACS) remain limited. In patients with non-ST-segment elevation ACS, OCT-guided PCI has been associated with a higher post-PCI fractional flow reserve compared to angiography guidance, providing detailed information on lesion characteristics and stent expansion2. Performing OCT-guided PCI in acute settings poses significant challenges due to the need for blood clearance, which may lead to complications such as slow flow, dissection, and distal embolisation3. We investigated whether OCT offers comparable clinical efficacy and safety to IVUS for patients with and without ACS in an all-comers PCI population.

In this post hoc analysis of the OCTIVUS trial with extended 2-year follow-up, we evaluated the outcomes of OCT versus IVUS guidance for PCI in ACS and non-ACS patients, building upon the initial 1-year non-inferiority findings4....

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 21 Number 10
May 16, 2025
Volume 21 Number 10
View full issue


Key metrics

Suggested by Cory

Viewpoint

Feb 16, 2026
PCR: a new era dawns
Prendergast B
free

Editorial

10.4244/EIJ-D-25-01330 Feb 16, 2026
Aspirin discontinuation after ACS: timing the transition to ticagrelor monotherapy
Gragnano F and Calabrò P
free

Editorial

10.4244/EIJ-D-25-01331 Feb 16, 2026
Will the dream of "leave nothing behind" remain a utopia if we forget to optimise the systemic medical therapy?
Wykrzykowska J and Kraak R
free

State-of-the-Art

10.4244/EIJ-D-25-00598 Feb 16, 2026
Adjunctive pharmacological strategies for residual risk reduction after myocardial revascularisation
Oshima A et al
free

Original Research

10.4244/EIJ-D-25-00618 Feb 16, 2026
Hertz contact intravascular lithotripsy for calcified coronary artery disease: the PINNACLE-I trial
Verheye S et al
open access

Flashlight

10.4244/EIJ-D-25-00431 Feb 16, 2026
A novel spacer for transcatheter treatment of tricuspid regurgitation
Barbieri F et al
open access
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved